Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127177071 | 12717707 | 1 | I | 20060330 | 20060414 | 20160906 | 20160906 | EXP | JP-ASTRAZENECA-2006AP01749 | ASTRAZENECA | 80.00 | YR | M | Y | 0.00000 | 20160906 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127177071 | 12717707 | 1 | PS | IRESSA | GEFITINIB | 1 | Oral | 5500 | MG | Y | 0 | 250 | MG | TABLET | QD | ||||
| 127177071 | 12717707 | 2 | C | OXYCONTIN | OXYCODONE HYDROCHLORIDE | 1 | Oral | 0 | 30 | MG | TABLET | TID | |||||||
| 127177071 | 12717707 | 3 | C | DAONIL | GLYBURIDE | 1 | Oral | 0 | 2.5 | MG | TABLET | QD | |||||||
| 127177071 | 12717707 | 4 | C | AMLODIN | AMLODIPINE BESYLATE | 1 | Oral | 0 | 5 | MG | TABLET | QD | |||||||
| 127177071 | 12717707 | 5 | C | PAXIL | PAROXETINE HYDROCHLORIDE | 1 | Oral | 0 | 10 | MG | TABLET | QD | |||||||
| 127177071 | 12717707 | 6 | C | MAGNESIUM OXIDE. | MAGNESIUM OXIDE | 1 | Oral | 0 | 2 | G | BID | ||||||||
| 127177071 | 12717707 | 7 | C | LOXONIN | LOXOPROFEN SODIUM | 1 | Oral | 0 | 60 | MG | TABLET | TID | |||||||
| 127177071 | 12717707 | 8 | C | CYTOTEC | MISOPROSTOL | 1 | Oral | 0 | 3 | DF | TABLET | TID | |||||||
| 127177071 | 12717707 | 9 | C | GASMOTIN | MOSAPRIDE CITRATE | 1 | Oral | 0 | 3 | DF | TABLET | TID | |||||||
| 127177071 | 12717707 | 10 | C | VINORELBINE DITARTRATE | VINORELBINE TARTRATE | 1 | Unknown | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127177071 | 12717707 | 1 | Lung adenocarcinoma |
| 127177071 | 12717707 | 2 | Pain |
| 127177071 | 12717707 | 3 | Diabetes mellitus |
| 127177071 | 12717707 | 4 | Hypertension |
| 127177071 | 12717707 | 5 | Decreased appetite |
| 127177071 | 12717707 | 6 | Constipation |
| 127177071 | 12717707 | 7 | Pain |
| 127177071 | 12717707 | 8 | Prophylaxis against gastrointestinal ulcer |
| 127177071 | 12717707 | 9 | Gastritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127177071 | 12717707 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127177071 | 12717707 | Lung disorder | |
| 127177071 | 12717707 | Rash |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127177071 | 12717707 | 1 | 20060322 | 20060412 | 0 |